Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease
Publication
, Journal Article
Califf, RM; Mark, DB
Published in: American Heart Journal
January 1, 1997
Duke Scholars
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
January 1, 1997
Volume
134
Issue
5 II
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., & Mark, D. B. (1997). Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease. American Heart Journal, 134(5 II). https://doi.org/10.1016/s0002-8703(97)80055-5
Califf, R. M., and D. B. Mark. “Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease.” American Heart Journal 134, no. 5 II (January 1, 1997). https://doi.org/10.1016/s0002-8703(97)80055-5.
Califf RM, Mark DB. Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease. American Heart Journal. 1997 Jan 1;134(5 II).
Califf, R. M., and D. B. Mark. “Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease.” American Heart Journal, vol. 134, no. 5 II, Jan. 1997. Scopus, doi:10.1016/s0002-8703(97)80055-5.
Califf RM, Mark DB. Issues of cost-effectiveness in the use of antithrombotic therapy for ischemic heart disease. American Heart Journal. 1997 Jan 1;134(5 II).
Published In
American Heart Journal
DOI
ISSN
0002-8703
Publication Date
January 1, 1997
Volume
134
Issue
5 II
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology